RecruitingNCT00001230

Host Response to Infection and Treatment in Filarial Diseases

Studying Filariasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator: Thomas B Nutman, M.D., M.D
National Institute of Allergy and Infectious Diseases (NIAID)
Intervention: Diethylcarbamazine(drug)
Enrollment: 500 enrolled
Eligibility: 3-100 years · All sexes
Timeline: 1991

Study locations (1)

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00001230 on ClinicalTrials.gov

← Back to all trials